DNA — Ginkgo Bioworks Holdings, Inc. stock price, charts and financials

QT32Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
9.37
+0.43+4.81%
OverviewShort InterestFilings
DNAQT32Ginkgo Bioworks Holdings, Inc.·NYSE
9.37+4.81%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20268-KCurrent report
Jul 30, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 30, 20264Statement of changes in beneficial ownership
Jul 20, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
May 26, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
Apr 29, 2026ARSAnnual report to shareholders
Apr 29, 2026DEF 14ADefinitive proxy statement
Apr 29, 2026DEFA14AAdditional proxy soliciting materials
Apr 20, 20264Statement of changes in beneficial ownership
Apr 17, 2026144Notice of proposed sale of restricted securities
Apr 15, 2026144Notice of proposed sale of restricted securities
Apr 14, 20264Statement of changes in beneficial ownership
Apr 13, 20264Statement of changes in beneficial ownership
Apr 13, 2026144Notice of proposed sale of restricted securities
Apr 13, 2026144Notice of proposed sale of restricted securities
#1 / 25 of 506
Page
▼
/ 21